stella
beta
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT — Stella
Recruiting
Back to Acute Myeloid Leukemia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Stanford University, Palo Alto, California
View full record on ClinicalTrials.gov